Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,109.14
(
-0.24%
)
US TECH 100
25,931.42
(
-0.09%
)
Dow Jones
49,442.56
(
-0.01%
)
Brent Oil
90.68
(
-2.14%
)
Bitcoin
75,954.85
(
2.83%
)
News Focus
News Focus
Post# of 822106
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

sukus

Send PM Follow Ignore
Followers 49
Posts 8921
Boards Moderated 0
Alias Born 05/27/2011

sukus

Re: VuBru post# 192468

Saturday, 10/06/2018 11:51:16 AM

Saturday, October 06, 2018 11:51:16 AM

Post# of 822106
I agree with you VuBru. If I remember correctly LP said the dcvax-l trial has been designed with various subtypes analysis. And we already know based on data presented the vaccine is highly correlated to certain subtype. This data speaks louder. This is a gift for longs here. If longs can’t appreciate it and still depressed due to price per share, I don’t know what to say. Use price to your own advantage. IMO.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News